Human neutrophil calprotectin reduces the susceptibility of Borrelia burgdorferi to penicillin

Infection and Immunity

Volumn 74, Issue 4, 2006, Pages 2468-2472

  Montgomery, Ruth R ^a   Schreck, Kimberly ^a   Wang, Xiaomei ^a   Malawista, Stephen E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CALPROTECTIN; CATION; CELL PROTEIN; CYTOPLASM PROTEIN; DOXYCYCLINE; PENICILLIN G; ZINC;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BORRELIA BURGDORFERI; BORRELIA INFECTION; CHELATION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG MECHANISM; HUMAN; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; LYME DISEASE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOGOUT; SPIROCHETE; SYNOVIAL FLUID;

ANTI-BACTERIAL AGENTS; ARTHRITIS; BORRELIA BURGDORFERI; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH INHIBITORS; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; NEUTROPHILS; PENICILLIN G; PENICILLIN RESISTANCE; SYNOVIAL FLUID;

EID: 33645507062     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.4.2468-2472.2006     Document Type: Article

References (34)

1. Barthold, S. W., C. L. Sidman, and A. L. Smith. 1992. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am. J. Trop. Med. Hyg. 47:605-613.
2. Berthier, S., M. H. Paclet, S. Lerouge, F. Roux, S. Vergnaud, A. W. Coleman, and F. Morel. 2003. Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation. J. Biol. Chem. 278:25499-25508.
3. Brooks, C. S., P. S. Hefty, S. E. Jolliff, and D. R. Akins. 2003. Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals. Infect. Immun. 71:3371-3383.
4. Garcia, R., L. Gusmani, R. Murgia, C. Guarnaccia, M. Cinco, and G. Rottini. 1998. Elastase is the only human neutrophil granule protein that alone is responsible for in vitro killing of Borrelia burgdorferi. Infect. Immun. 66:1408-1412.
5. Geczy, C. 1996. Regulation and proinflammatory properties of the chemotactic protein, CP-10. Biochim. Biophys. Acta 1313:246-252.
6. Hessian, P. A., J. Edgeworth, and N. Hogg. 1993. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J. Leukoc. Biol. 53:197-204.
7. Hogg, N., C. Allen, and J. Edgeworth. 1989. Monoclonal antibody 5.5 reacts with p8,14, a myeloid molecule associated with some vascular endothelium. Eur. J. Immunol. 19:1053-1061.
8. Hunter, M. J., and W. J. Chazin. 1998. High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14. J. Biol. Chem. 273:12427-12435.
9. Johne, B., M. K. Fagerhol, T. Lyberg, H. Prydz, P. Brandtzaeg, C. F. Naess-Andresen, and I. Dale. 1997. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol. Pathol. 50:113-123.
10. Kocher, M., P. A. Kenny, E. Farram, K. B. Abdul Majid, J. J. Finlay-Jones, and C. L. Geczy. 1996. Functional chemotactic factor CP-10 and MRP-14 are abundant in murine abscesses. Infect. Immun. 64:1342-1350.
11. Loomans, H. J., B. L. Hahn, Q. Q. Li, S. H. Phadnis, and P. G. Sohnle. 1998. Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. J. Infect. Dis. 177:812-814.
12. Lusitani, D., S. E. Malawista, and R. R. Montgomery. 2002. Borrelia burgdorferi are susceptible to killing by a variety of PMN components. J. Infect. Dis. 185:797-804.
13. Lusitani, D. L., S. E. Malawista, and R. R. Montgomery. 2003. Calprotectin, an abundant cytosolic protein from human polymorphonuclear leukocytes, inhibits the growth of Borrelia burgdorferi. Infect. Immun. 71:4711-4716.
14. Malawista, S. E. 2005. Lyme disease, p. 2645-2664. In W. J. Koopman and L. W. Moreland (ed.), Arthritis and allied conditions. A textbook of rheumatology, 15th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
15. Mambula, S. S., E. R. Simons, R. Hastey, M. E. Selsted, and S. M. Levitz. 2000. Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans. Infect. Immun. 68:6257-6264.
16. Montgomery, R. R., D. L. Lusitani, A. de Boisfleury Chevance, and S. E. Malawista. 2002. Human phagocytic cells in the early innate immune response to Borrelia burgdorferi. J. Infect. Dis. 185:1773-1779.
17. Montgomery, R. R., M. H. Nathanson, and S. E. Malawista. 1993. The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages: destruction, survival, recovery. J. Immunol. 150:909-915.
18. Montgomery, R. R., X. Wang, and S. E. Malawista. 2001. Murine Lyme disease: no evidence for active immune downregulation in resolving or subclinical infection. J. Infect. Dis. 183:1631-1637.
19. Murthy, A. R., R. I. Lehrer, S. S. Harwig, and K. T. Miyasaki. 1993. In vitro candidastatic properties of the human neutrophil calprotectin complex. J. Immunol. 151:6291-6301.
20. Newton, R. A., and N. Hogg. 1998. The human S100 protein MRP-14 is a novel activator of the b2 integrin Mac-1 on neutrophils. J. Immunol. 160:1427-1435.
21. Ojaimi, C., C. Brooks, S. Casjens, P. Rosa, A. Elias, A. Barbour, A. Jasinskas, J. Benach, L. Katona, J. Radolf, M. Caimano, J. Skare, K. Swingle, D. Akins, and I. Schwartz. 2003. Profiling of temperature-induced changes in Borrelia burgdorferi gene expression by using whole genome arrays. Infect. Immun. 71:1689-1705.
22. Okutomi, T., T. Tanaka, S. Yui, M. Mikami, M. Yamazaki, S. Abe, and H. Yamaguchi. 1998. Anti-Candida activity of calprotectin in combination with neutrophils or lactoferrin. Microbiol. Immunol. 42:789-793.
23. Pal, U., and E. Fikrig. 2003. Adaptation of Borrelia burgdorferi in the vector and vertebrate host. Microbes Infect. 5:659-666.
24. Pal, U., R. R. Montgomery, D. Lusilani, P. Voet, V. Weynants, S. E. Malawista, Y. Lobet, and E. Fikrig. 2001. Inhibition of Borrelia burgdorferi-tick interactions in vivo by OspA antibody. J. Immunol. 166:7398-7403.
25. Posey, J. E., and F. C. Gherardini. 2000. Lack of a role for iron in the Lyme disease pathogen. Science 288:1651-1653.
26. Revel, A. T., A. M. Talaat, and M. V. Norgard. 2002. DNA microarray analysis of differential gene expression in Borrelia burgdorferi, the Lyme disease spirochete. Proc. Natl. Acad. Sci. USA 99:1562-1567.
27. Roulin, K., G. Hagens, R. Hotz, J. H. Saurat, J. H. Veerkamp, and G. Siegenthaler. 1999. The fatty acid-binding heterocomplex FA-p34 formed by S100A8 and S100A9 is the major fatty acid carrier in neutrophils and translocates from the cytosol to the membrane upon stimulation. Exp. Cell Res. 247:410-421.
28. Ryckman, C., S. R. McColl, K. Vandal, R. de Medicis, A. Lussier, P. E. Poubelle, and P. A. Tessier. 2003. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum. 48:2310-2320.
29. Ryckman, C., K. Vandal, P. Rouleau, M. Talbot, and P. A. Tessier. 2003. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 170:3233-3242.
30. Schaible, U. E., M. D. Kramer, C. Museteanu, G. Zimmer, H. Mossmann, and M. M. Simon. 1989. The severe combined immunodeficiency (scid) mouse: a laboratory model for the analysis of Lyme arthritis and carditis. J. Exp. Med. 170:1427-1432.
31. Sohnle, P. G., M. J. Hunter, B. Hahn, and W. J. Chazin. 2000. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J. Infect. Dis. 182:1272-1275.
32. Steinbakk, M., C. F. Naess-Andresen, E. Lingaas, I. Dale, P. Brandtzaeg, and M. K. Fagerhol. 1990. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 336:763-765.
33. Vandal, K., P. Rouleau, A. Boivin, C. Ryckman, M. Talbot, and P. A. Tessier. 2003. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J. Immunol. 171:2602-2609.
34. Watt, K. W., I. L. Brightman, and E. J. Goetzl. 1983. Isolation of two polypeptides comprising the neutrophil-immobilizing factor of human leucocytes. Immunology 48:79-86.